Zhanzhan Li

Zhanzhan Li

Auto-generated profile, based on publicly available information

Zhanzhan Li

Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2018 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
TWTingting Wang
Tingting Wang
HFHanlin Fu
Hanlin Fu
AKAtipatsa Chiwanda Kaminga
Atipatsa Chiwanda Kaminga
ZLZhanzhan Li
Zhanzhan Li
GGGuiping Guo
Guiping Guo
QLQiongxuan Li
Qiongxuan Li
The number of people living with HIV/AIDS (PLHA) in China continues to increase. Depression, a common mental disorder in this population, may confer a higher likelihood of worse health outcomes. An estimate of the prevalence of this disorder among PLHA is required to guide public health policy, but the published results vary widely and lack accuracy in China. The goal of this study was to estimate the pooled prevalence of depression or depressive symptoms among PLHA in China. A systematic literature search of several databases was conducted from inception to June 2017, focusing on studies reporting on depression or depressive symptoms among PLHA in China. The risk of bias of individual studies was assessed using a modified version of the Newcastle-Ottawa scale. The overall prevalence estimates were pooled using random-effects meta-analysis. Differences according to study-level characteristics were examined using stratified meta-analysis and meta-regression. Seventy-four observational studies including a total of 20,635 PLHA were included. The pooled prevalence of depression or depressive symptoms was 50.8% (95% CI: 46.0–55.5%) among general PLHA, 43.9% (95% CI: 36.2–51.9%) among HIV-positive men who have sex with men, 85.6% (95% CI: 64.1–95.2%) among HIV-positive former blood/plasma donors, and 51.6% (95% CI: 31.9–70.8%) among other HIV-positive populations. Significant heterogeneity was detected across studies regarding these prevalence estimates. Heterogeneity in the prevalence of depression among the general population of PLHA was partially explained by the geographic location and baseline survey year. Because of the significant heterogeneity detected across studies regarding these prevalence estimates of depression or depressive symptoms, the results must be interpreted with caution. Our findings suggest that the estimates of depression or depressive symptoms among PLHA in China are considerable, which highlights the need to integrate screening and providing treatment for mental disorders in the treatment package offered to PLHA, which would ultimately lead to better health outcomes in PLHA.

15 February 2019 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
PCPeng Chen
Peng Chen
YHYihe Hu
Yihe Hu
ZLZhanzhan Li
Zhanzhan Li
We searched several databases from the times of their inception to December 20, 2018. Randomized controlled trials and cohort studies that compared percutaneous endoscopic transforaminal discectomy (PETD) with percutaneous endoscopic interlaminar discectomy (PEID) were identified. We used a random-effects model to calculate the relative risks of, and standardized mean differences (SMDs) between, the two techniques, with 95% confidence intervals (CIs). Twenty-six studies with 3,294 patients were included in the final analysis. Compared with PEID, PETD reduced the short-term (SMD -0.68; 95% CI -1.01, -0.34; P =0.000) and long-term (SMD -0.47; 95% CI -0.82, -0.12; P =0.000) visual analog scale scores, blood loss (SMD -4.75; 95% CI -5.80, -3.71; P =0.000), duration of hospital stay (SMD -1.86; 95% CI -2.36, -1.37; P =0.000), and length of incision (SMD -3.93; 95% CI -5.23, -2.62; P =0.000). However, PEID was associated with a lower recurrence rate ( P =0.035) and a shorter operative time ( P =0.014). PETD and PEID afforded comparable excellent- and good-quality data, long- and short-term Oswestry disability index scores, and complication rates. PETD treated lumbar disc herniation (LDH) more effectively than did PEID. Although PETD required a longer operative time, PETD was as safe as PEID, and was associated with less blood loss, a shorter hospital stay, and a shorter incision. PETD is the best option for patients with LDH.

5 October 2018 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
JFJun Fu
Jun Fu
YLYanyan Li
Yanyan Li
ZLZhanzhan Li
Zhanzhan Li
NLNa Li
Na Li
We conducted a comprehensive analysis to evaluate clinical utility of decarboxylation prothrombin combined with α-fetoprotein (AFP) for diagnosing primary hepatocellular carcinoma (HCC). Systematical searches were performed in PubMed, Web of Science, China National Knowledge Internet, and Wangfang databases. The bivariate random-effect model was used to calculate the pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood, diagnostic odds ratio (DOR), and summary area under the curve (AUC). Fourteen studies were included in the meta-analysis. For decarboxylation prothrombin, the overall pooled parameters are as follows: sensitivity: 79% (95% confidence interval (CI): 74–84%), specificity: 91% (95%CI: 87–93%), PLR: 8.42 (95%CI: 5.79–12.23), negative likelihood ratio (NLR): 0.23 (95%CI: 0.17–0.30), DOR: 37.09 (95%CI: 21.37–64.36), summary AUC: 0.92 (95%CI: 0.89–0.94); for combined diagnostic, the overall pooled parameters were as follows: sensitivity: 91% (95%CI: 85–95%), specificity: 83% (95%CI: 74–89%), PLR: 5.26 (95%CI: 3.53–7.83), NLR: 0.11 (95%CI: 0.07–0.18), DOR: 47.14 (95%CI: 30.09–73.85), summary AUC: 0.94 (95%CI: 0.91–0.95). The serum decarboxylation prothrombin showed a relatively higher diagnostic specificity for primary HCC and decarboxylation prothrombin combined with AFP exhibited can improve sensitivity for HCC than any of the biomarkers alone.

20 September 2019 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
HPHaiqin Peng
Haiqin Peng
ZLZhanzhan Li
Zhanzhan Li
YLYujiao Long
Yujiao Long
JLJiahui Li
Jiahui Li
ZLZhiyuan Liu
Zhiyuan Liu
RZRongrong Zhou
Rongrong Zhou
Background: To evaluate the diagnostic value of Epstein–Barr virus (EBV) DNA in nasopharyngeal carcinoma (NPC) patients with locoregional or distant recurrence. Methods: Articles related to the diagnosis of recurrent or metastatic NPC by the detection of EBV DNA in plasma or serum were retrieved from different databases. Sensitivity, specificity, summary receiver operating characteristic (SROC) curves, and likelihood ratios were pooled to assess the diagnostic value of individual diagnostic tests. Results: This meta-analysis pooled 25 eligible studies including 2496 patients with NPC. The sensitivity, specificity, positive likelihood ratio (+LR), and negative likelihood ratio (−LR) of EBV DNA in the diagnosis of NPC were 0.858 (95% confidence interval (CI): 0.801–0.901), 0.890 (95% CI: 0.866–0.909), 7.782 (95% CI: 6.423–9.429) and 0.159 (95% CI: 0.112–0.226), respectively. The diagnostic odds ratio (DOR) was 48.865 (95% CI: 31.903–74.845). The SROC for EBV DNA detection was 0.93 (95% CI: 0.90–0.95). Conclusion: The detection of EBV DNA for the diagnosis of recurrent or metastatic NPC has good sensitivity and specificity and might be helpful in monitoring recurrent or metastatic NPC.

28 January 2017 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
DRDongdong Ren
Dongdong Ren
JWJuan Wang
Juan Wang
HLHua Li
Hua Li
YLYanyan Li
Yanyan Li
ZLZhanzhan Li
Zhanzhan Li
To evaluate the relationship between red blood cell distribution width (RDW) and carotid intima-media thickness (CIMT) in metabolic syndrome (MetS) patients. In this study, we analyzed 803 patients with MetS who underwent carotid ultrasonography examination at Henan Province Hospital of Traditional Chinese Medicine from October 2014 to September 2015. Demographic data were collected using a questionnaire. An automatic biochemistry analyzer measured RDW. Pearson correlation coefficient, multivariate linear and logistic regression was used to evaluate the correlation between RDW and CIMT. Compared with control group, case group had higher RDW level (P < 0.001) and CIMT (P < 0.001). CIMT was positively related to RDW (r = 0.436, P < 0.001). Logistic regression indicated that RDW was a predictor of CIMT ≥ 1 mm. Compared with the first quartile, people with third and fourth quartile level gave obvious higher risk of carotid artery atherosclerotic trend (OR = 1.41, 95% CI:1.01–197; OR = 2.10, 95% CI: 1.30–3.40). Using a cutoff point of 13.9%, RDW predicts elevated CIMT with a sensitivity of 62.1% and a specificity of 70.3%. High RDW is related to the increased CIMT in MetS patients, which highlights the role of RDW in the progression of elevated CIMT in MetS patients.

24 May 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
HWHuiqing Wang
Huiqing Wang
TWTingting Wang
Tingting Wang
WSWenpei Shi
Wenpei Shi
YLYuan Liu
Yuan Liu
LCLiZhang Chen
LiZhang Chen
ZLZhanzhan Li
Zhanzhan Li
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Huiqing Wang1, Tingting Wang1, Wenpei Shi1, Yuan Liu1, Lizhang Chen1 and Zhanzhan Li2 1Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, Hunan Province 410078, China 2Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China Correspondence to: Zhanzhan Li, email: liche4006@126.com Lizhang Chen, email: liche4005@126.com Keywords: diagnostic, ovarian cancer, miRNA, meta-analysis Received: February 25, 2017 Accepted: April 07, 2017 Published: May 24, 2017 ABSTRACT We performed a meta-analysis to assess the diagnostic accuracy of circulating miRNA for patients with ovarian cancer. We systematically searched several online databases, including PubMed, Web of Science, Chinese National Knowledge Infrastructure, and Wanfang from inception to February 20, 2017. We used the bivariate mixed-effect models to pool positive likelihood ratios, negative likelihood ratios, diagnostic odds ratios and their 95% CI confidence intervals (CIs). We used the Quality Assessment of Diagnostic Accuracy Studies 2 for quality assessment of diagnostic accuracy studies. This meta-analysis included ten studies with the number of 1356 participants. The pooled sensitivity and specificity were 0.75 (95%CI: 0.69-0.80) and 0.75 (95%CI: 0.69-0.81). We also calculated the positive likelihood ratios (3.03, 95%CI: 2.44-3.76), and negative likelihood ratios (0.33, 95%CI: 0.27-0.41). The diagnostic odds ratio was 9.09 (95%CI: 6.51-12.69). The summary receiver operator characteristic was 0.82 (95%CI: 0.78-0.85). Sensitivity analysis showed similar results. No publication bias existed (t=0.380, P=0.712). The diagnostic ability of miRNAs were moderate for ovarian cancer. Further research was required to obtain accurate results.